Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

Published 2020 View Full Article

Title

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

Authors

Keywords

BMI, PD-1/PD-L1, Overweight, Obesity, Cancer, Immunotherapy, Checkpoint inhibitors, Immune-related adverse events

Journal

EUROPEAN JOURNAL OF CANCER

Volume 128, Issue -, Pages 17-26

Publisher

Elsevier BV

Online

2020-03-09

DOI

10.1016/j.ejca.2019.12.031

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

© Peeref 2019-2024. All rights reserved.